{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:58:12Z","timestamp":1788245892250,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jid.2018.03.1515","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T03:13:14Z","timestamp":1522033994000},"page":"1917-1924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Identification of Immunodominant Th2-Cell\u00a0Epitopes in Chinese Patients with\u00a0Bullous Pemphigoid"],"prefix":"10.1016","volume":"138","author":[{"given":"Jieyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erle","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuju","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjiang","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2018.03.1515_bib1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.autrev.2017.03.010","article-title":"Bullous pemphigoid","volume":"16","author":"Bagci","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jid.2018.03.1515_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40257-017-0264-2","article-title":"Bullous pemphigoid: a review of its diagnosis, associations and treatment","volume":"18","author":"Bernard","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jid.2018.03.1515_bib4","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.4049\/jimmunol.1102689","article-title":"Soluble CD23 controls IgE synthesis and homeostasis in human B cells","volume":"188","author":"Cooper","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2018.03.1515_bib5","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2008.11.035","article-title":"Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab","volume":"123","author":"Fairley","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2018.03.1515_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-4632.2008.03473.x","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"47","author":"Feng","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2018.03.1515_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1365-2230.2002.01037.x","article-title":"HLA-DR and DQ polymorphisms in bullous pemphigoid from northern China","volume":"27","author":"Gao","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2018.03.1515_bib8","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.4049\/jimmunol.164.12.6138","article-title":"Analysis of soluble and cell surface factors regulating anti-DNA topoisomerase I autoantibody production demonstrates synergy between Th1 and Th2 autoreactive T cells","volume":"164","author":"Kuwana","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2018.03.1515_bib9","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1046\/j.1523-1747.2000.00153.x","article-title":"Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain","volume":"115","author":"Lin","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.03.1515_bib10","doi-asserted-by":"crossref","first-page":"25629","DOI":"10.1038\/srep25629","article-title":"CD23 can negatively regulate B-cell receptor signaling","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2018.03.1515_bib11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model","volume":"31","author":"Liu","year":"2008","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jid.2018.03.1515_bib12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4049\/jimmunol.1001753","article-title":"FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid","volume":"187","author":"Messingham","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2018.03.1515_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/cei.12566","article-title":"T\u00a0cell participation in autoreactivity to NC16a epitopes in bullous pemphigoid","volume":"180","author":"Pickford","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jid.2018.03.1515_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T\u00a0cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jid.2018.03.1515_bib15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2018.03.1515_bib16","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.4049\/jimmunol.176.3.2015","article-title":"Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230","volume":"176","author":"Thoma-Uszynski","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2018.03.1515_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jdermsci.2004.10.007","article-title":"Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid","volume":"37","author":"Tsuji-Abe","year":"2005","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2018.03.1515_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jdermsci.2015.03.002","article-title":"IgE autoantibodies in bullous pemphigoid: supporting role, or leading player?","volume":"78","author":"Ujiie","year":"2015","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2018.03.1515_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.clim.2011.10.002","article-title":"Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model","volume":"142","author":"Ujiie","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jid.2018.03.1515_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1586\/1744666X.2016.1123092","article-title":"IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases","volume":"12","author":"van Beek","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jid.2018.03.1515_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamadermatol.2016.3357","article-title":"Correlation of serum levels of IgE autoantibodies against BP180 with bullous pemphigoid disease activity","volume":"153","author":"van Beek","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2018.03.1515_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4049\/jimmunol.170.1.635","article-title":"Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles","volume":"170","author":"Veldman","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2018.03.1515_bib22","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2353\/ajpath.2010.090744","article-title":"Blockade of autoantibody-initiated tissue damage by using recombinant fab antibody fragments against pathogenic autoantigen","volume":"176","author":"Wang","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2018.03.1515_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.autrev.2011.07.002","article-title":"Role of MHC Class II genes in the pathogenesis of pemphigoid","volume":"11","author":"Zakka","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jid.2018.03.1515_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clindermatol.2011.03.005","article-title":"Bullous pemphigoid: from the clinic to the bench","volume":"30","author":"Di Zenzo","year":"2012","journal-title":"Clin Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18318062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18318062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T01:10:41Z","timestamp":1567300241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X18318062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0022202X18318062"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2018.03.1515","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of Immunodominant Th2-Cell\u00a0Epitopes in Chinese Patients with\u00a0Bullous Pemphigoid","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2018.03.1515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}